Literature DB >> 8262056

Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation.

N Kruse1, B J Shen, S Arnold, H P Tony, T Müller, W Sebald.   

Abstract

Interleukin 4 (IL-4) exerts a decisive role in the coordination of protective immune responses against parasites, particularly helminths. A disregulation of IL-4 function is possibly involved in the genesis of allergic disease states. The search for important amino acid residues in human IL-4 by mutational analysis of charged invariant amino acid positions identified two distinct functional sites in the 4-helix-bundle protein. Site 1 was marked by amino acid substitutions of the glutamic acid at position 9 in helix A and arginine at position 88 in helix C. Exchanges at both positions led to IL-4 variants deficient in binding to the extracellular domain of the IL-4 receptor (IL-4R(ex)). In parallel, up to 1000-fold increased concentrations of this type of variant were required to induce T-cell proliferation and B-cell CD23 expression. Site 2 was marked by amino acid exchanges in helix D at positions 121, 124 and 125 (arginine, tyrosine and serine respectively in the wild-type). IL-4 variants affected at site 2 exhibited partial agonist activity during T-cell proliferation; however, they still bound with high affinity to IL-4R(ex). [The generation of an IL-4 antagonist by replacing tyrosine 124 with aspartic acid has been described before by Kruse et al. (1992) (EMBO J., 11, 3237-3244)]. These findings indicate that IL-4 functions by binding IL-4R(ex) via site 1 which is constituted by residues on helices A and C.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262056      PMCID: PMC413774          DOI: 10.1002/j.1460-2075.1993.tb06207.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  64 in total

1.  Rational design of potent antagonists to the human growth hormone receptor.

Authors:  G Fuh; B C Cunningham; R Fukunaga; S Nagata; D V Goeddel; J A Wells
Journal:  Science       Date:  1992-06-19       Impact factor: 47.728

2.  Structural design and molecular evolution of a cytokine receptor superfamily.

Authors:  J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Localization in human interleukin 2 of the binding site to the alpha chain (p55) of the interleukin 2 receptor.

Authors:  K Sauvé; M Nachman; C Spence; P Bailon; E Campbell; W H Tsien; J A Kondas; J Hakimi; G Ju
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 4.  GM-CSF receptor: interactions and activation.

Authors:  R A Kastelein; A B Shanafelt
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

5.  Human interleukin 4. The solution structure of a four-helix bundle protein.

Authors:  L J Smith; C Redfield; J Boyd; G M Lawrence; R G Edwards; R A Smith; C M Dobson
Journal:  J Mol Biol       Date:  1992-04-20       Impact factor: 5.469

6.  Molecular cloning of a cDNA encoding the human interleukin 4 receptor.

Authors:  J P Galizzi; C E Zuber; N Harada; D M Gorman; O Djossou; R Kastelein; J Banchereau; M Howard; A Miyajima
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

7.  Independent regulation of interleukin 4 (IL-4)-induced expression of human B cell surface CD23 and IgM: functional evidence for two IL-4 receptors.

Authors:  K P Rigley; S M Thurstan; R E Callard
Journal:  Int Immunol       Date:  1991-02       Impact factor: 4.823

8.  Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain.

Authors:  S D Voss; T P Leary; P M Sondel; R J Robb
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Mutant proteins of human interleukin 2. Renaturation yield, proliferative activity and receptor binding.

Authors:  U Weigel; M Meyer; W Sebald
Journal:  Eur J Biochem       Date:  1989-03-15

10.  The chimeric receptor between interleukin-2 receptor beta chain and interleukin-4 receptor transduces interleukin-2 signal.

Authors:  K Izuhara; A Miyajima; N Harada
Journal:  Biochem Biophys Res Commun       Date:  1993-02-15       Impact factor: 3.575

View more
  20 in total

1.  Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.

Authors:  R M Arduini; K L Strauch; L A Runkel; M M Carlson; X Hronowski; S F Foley; C N Young; W Cheng; P S Hochman; D P Baker
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

2.  The RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis Inactivate the Th2 cytokines interleukin-4 and interleukin-5.

Authors:  Vivian Tam; Neil M O'Brien-Simpson; Yu-Yen Chen; Colin J Sanderson; Beverley Kinnear; Eric C Reynolds
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

3.  Gamma chain receptor interleukins: evidence for positive selection driving the evolution of cell-to-cell communicators in the mammalian immune system.

Authors:  Mary J O'Connell; James O McInerney
Journal:  J Mol Evol       Date:  2005-10-04       Impact factor: 2.395

4.  Interaction affinity between cytokine receptor components on the cell surface.

Authors:  A Whitty; N Raskin; D L Olson; C W Borysenko; C M Ambrose; C D Benjamin; L C Burkly
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

5.  IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain.

Authors:  R L Palmer-Crocker; C C Hughes; J S Pober
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

6.  Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor.

Authors:  R Brock; K H Wiesmüller; G Jung; P Walden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

7.  LIF receptor-gp130 interaction investigated by homology modeling: implications for LIF binding.

Authors:  D K Smith; H R Treutlein
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

8.  Comparative model building of interleukin-7 using interleukin-4 as a template: a structural hypothesis that displays atypical surface chemistry in helix D important for receptor activation.

Authors:  L Cosenza; A Rosenbach; J V White; J R Murphy; T Smith
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

9.  Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).

Authors:  B König; A Fischer; W König
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

10.  An immune cell-selective interleukin 4 agonist.

Authors:  A B Shanafelt; C P Forte; J J Kasper; L Sanchez-Pescador; M Wetzel; R Gundel; J M Greve
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.